AQEMIA (Series A)
Funding Details
Awarder
Inbox
Date Award
December 10, 2024
Vertical
Biotech and Health
Funding URL
View Funding Page
Funding Amount
$38,000,000
Company Info
Founding Year
2019
Traction
Aqemia has signed a multi-year agreement with French pharmaceutical giant Sanofi, potentially worth up to $140 million depending on R&D milestones.
Organizations Involved
Sanofi
Founders
Maximilien Levesque, Emmanuelle Rolland-Martiano
Market
Drug Discovery
Location
Paris, France
Coinvestors
Wendel, Bpifrance Large Venture, Eurazeo, Elaia
Company Description

Aqemia accelerates drug discovery using quantum physics and AI, generating novel drug candidates without experimental data.

Links
WebsiteCrunchbaseLinkedInTwitter
Back to HomeBack to Biotech and Health DealsView Funding Announcement